| scholarly article | Q13442814 |
| P2093 | author name string | David E Smith | |
| Yongjun Hu | |||
| Daniel Epling | |||
| P2860 | cites work | Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model | Q28366175 |
| Mammalian peptide transporters as targets for drug delivery | Q33184402 | ||
| Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine | Q33358999 | ||
| Significance and regional dependency of peptide transporter (PEPT) 1 in the intestinal permeability of glycylsarcosine: in situ single-pass perfusion studies in wild-type and Pept1 knockout mice | Q34211071 | ||
| Development and characterization of a novel mouse line humanized for the intestinal peptide transporter PEPT1 | Q34293583 | ||
| Valacyclovir in the treatment of genital herpes and herpes zoster | Q34482036 | ||
| Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers | Q34729029 | ||
| Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans | Q35120940 | ||
| Effect of Dose Escalation on the In Vivo Oral Absorption and Disposition of Glycylsarcosine in Wild-Type andPept1Knockout Mice | Q35579541 | ||
| Species-Dependent Uptake of Glycylsarcosine but Not Oseltamivir in Pichia pastoris Expressing the Rat, Mouse, and Human Intestinal Peptide Transporter PEPT1 | Q36057398 | ||
| Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. | Q36535786 | ||
| Significance of Peptide Transporter 1 in the Intestinal Permeability of Valacyclovir in Wild-Type and PepT1 Knockout Mice | Q36642360 | ||
| Species differences in the pharmacokinetics of cefadroxil as determined in wildtype and humanized PepT1 mice | Q36767617 | ||
| Impact of Peptide Transporter 1 on the Intestinal Absorption and Pharmacokinetics of Valacyclovir after Oral Dose Escalation in Wild-Type and PepT1 Knockout Mice | Q37193116 | ||
| In Vivo Absorption and Disposition of Cefadroxil After Escalating Oral Doses in Wild-Type and PepT1 Knockout Mice | Q37351275 | ||
| Drug transport via the intestinal peptide transporter PepT1. | Q38134452 | ||
| Effects of progesterone and norethisterone on cephalexin transport and peptide transporter PEPT1 expression in human intestinal cell line Caco-2. | Q40333659 | ||
| Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. | Q40877910 | ||
| Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line | Q40965871 | ||
| Delineation of human peptide transporter 1 (hPepT1)-mediated uptake and transport of substrates with varying transporter affinities utilizing stably transfected hPepT1/Madin-Darby canine kidney clones and Caco-2 cells. | Q42478498 | ||
| Computational modelling of H+-coupled peptide transport via human PEPT1. | Q46414648 | ||
| Calculation of the aqueous diffusion layer resistance for absorption in a tube: application to intestinal membrane permeability determination | Q46603960 | ||
| 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter | Q47678868 | ||
| Metabolic disposition of the acyclovir prodrug valaciclovir in the rat. | Q48205154 | ||
| Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir | Q48932058 | ||
| In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation | Q50512905 | ||
| Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells | Q50719104 | ||
| Modern prodrug design for targeted oral drug delivery. | Q51042522 | ||
| A compartmental absorption and transit model for estimating oral drug absorption | Q52204779 | ||
| Metabolic fate and pharmacokinetics of the acyclovir prodrug valaciclovir in cynomolgus monkeys | Q72345065 | ||
| Cellular expression of monocarboxylate transporters (MCT) in the digestive tract of the mouse, rat, and humans, with special reference to slc5a8 | Q79350813 | ||
| P304 | page(s) | 1-7 | |
| P577 | publication date | 2018-06-21 | |
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | Evaluating the intestinal and oral absorption of the prodrug valacyclovir in wildtype and huPepT1 transgenic mice | |
| P478 | volume | 155 |
Search more.